SlideShare une entreprise Scribd logo
1  sur  29
InflammationInflammation
Jan Laco, M.D., Ph.D.
InflammationInflammation
complex protective reaction
caused by various endo- and exogenous
stimuli
injurious agents are destroyed, diluted or
walled-off
without inflammation and mechanism of
healing could organism not survive
can be potentially harmfull
TerminologyTerminology
Greek root + -itis
metritis, not uteritis
kolpitis, not vaginitis
nephritis, not renitis
MechanismsMechanisms
 local - in cases of mild injury
 systemic
 3 major:
 1. alteration
 2. exsudation - inflammatory exsudate
– liquid (exsudate)
– cellular (infiltrate)
 3. proliferation (formation of granulation and
fibrous tissue)
 usualy - all 3 components - not the same intensity
ClassificationClassification
 several points of view
 length:
– acute × chronic (+ subacute, hyperacute)
 according to predominant component
– 1. alterative (predominance of necrosis - diphtheria)
– 2. exsudative (pleuritis)
– 3. proliferative (cholecystitis - thickening of the wall by
fibrous tissue)
ClassificationClassification
 according to histological features
– nonspecific (not possible to trace the etiology) - vast
majority
– specific (e.g. TB)
 according to causative agent
– aseptic (sterile) - chemical substances, congelation,
radiation - inflammation has a reparative character
– septic (caused by living organisms) - inflammation has
a protective character
Acute inflammationAcute inflammation
important role in inflammation has
microcirculation!
supply of white blood cells, interleukins,
fibrin, etc.
Local symptomatologyLocal symptomatology
classical 5 symptoms (Celsus 1st c. B.C.,
Virchow 19th c. A.D.)
1. calor - heat
2. rubor - redness
3. tumor - swelling
4. dolor - pain
5. functio laesa - loss (or impairment) of
function
Systemic symptomatologySystemic symptomatology
 fever (irritation of centre of thermoregulation)
– TNF, IL-1
– IL-6 – high erythrocyte sedimentation rate
 leucocytosis - increased number of WBC
– bacteria – neutrophils
– parasites – eosinophils
– viruses - lymphocytosis
 leucopenia - decreased " "
– viral infections, salmonella infections, rickettsiosis
 immunologic reactions - increased level of some
substances (C-reactive protein)
Vascular changesVascular changes
 vasodilation
– increased permeability of vessels due to widened
intercell. junctions and contraction of endothelial cells
(histamin, VEGF, bradykinin)
 protein poor transudate (edema)
 protein rich exsudate
 leukocyte-dependent endothelial injury
– proteolysis – protein leakage
 → platelet adhesion → thrombosis
Cellular eventsCellular events
 leukocytes margination → rolling → adhesion →
transmigration
 emigration of:
– neutrophils (1-2 days)
– monocytes (2-3 days)
 chemotaxis
– endogenous signaling molecules - lymphokines
– exogenous - toxins
 phagocytosis - lysosomal enzymes, free radicals,
oxidative burst
 passive emigration of RBC - no active role in
inflamm. - hemorrhagic inflammation
PhagocytosisPhagocytosis
adhesion and invagination into cytoplasm
engulfment
lysosomes - destruction
in highly virulent microorganisms can die
leucocyte and not the microbe
in highly resistant microorganisms -
persistence within macrophage - activation
after many years
Outcomes of acute inflammationOutcomes of acute inflammation
 1. resolution - restoration to normal, limited injury
– chemical substances neutralization
– normalization of vasc. permeability
– apoptosis of inflammatory cells
– lymphatic drainage
 2. healing by scar
– tissue destruction
– fibrinous inflammtion
– purulent infl. → abscess formation (pus, pyogenic
membrane, resorption - pseudoxanthoma cells - weeks
to months)
 3. progression into chronic inflammation
Chronic inflammationChronic inflammation
reasons:
– persisting infection or prolonged exposure to
irritants (intracell. surviving of agents - TBC)
– repeated acute inflamations (otitis, rhinitis)
– primary chronic inflammation - low virulence,
sterile inflammations (silicosis)
– autoimmune reactions (rheumatoid arthritis,
glomerulonephritis, multiple sclerosis)
Chronic inflammationChronic inflammation
 chronic inflammatory cells ("round cell" infiltrate)
– lymphocytes
– plasma cells
– monocytes/macrophages activation of macrophages by
various mediators - fight against invaders
 lymphocytes → plasma cells, cytotoxic (NK)
cells, coordination with other parts of immune
system
 plasma cells - production of Ig
 monocytes-macrophages-specialized cells
(siderophages, gitter cells, mucophages)
Morphologic patterns ofMorphologic patterns of
inflammationinflammation
 1. alterative
 2. exsudative
– 2a. serous
– 2b. fibrinous
– 2c. suppurative
– 2d. pseudomembranous
– 2e. necrotizing, gangrenous
 3. proliferative
– primary (rare) x secondary (cholecystitis)
Morphologic patterns ofMorphologic patterns of
inflammationinflammation
 2a. serous - excessive accumulation of fluid, few
proteins - skin blister, serous membranes - initial
phases of inflamm.
 modification - catarrhal - accumulation of mucus
 2b. fibrinous - higher vascular permeability -
exsudation of fibrinogen -> fibrin - e.g.
pericarditis (cor villosum, cor hirsutum - "hairy"
heart
 fibrinolysis → resolution; organization → fibrosis
→ scar
 2c. suppurative (purulent) - accumulation of
neutrophillic leucocytes - formation of pus
(pyogenic bacteria)
 interstitial
– phlegmone – diffuse soft tissue
– abscess - localized collection
 acute – border – surrounding tissue
 chronic – border - pyogenic membrane
 Pseudoabscess – pus in lumen of hollow organ
 formation of suppurative fistule
 accumulation of pus in preformed cavities -
empyema (gallbladder, thoracic)
 complications of suppurative inflamm.:
 bacteremia (no clinical symptoms!; danger of
formation of secondary foci of inflamm.
(endocarditis, meningitis)
 sepsis (= massive bacteremia) - septic fever,
activation of spleen, septic shock
 thrombophlebitis - secondary inflammation of
wall of the vein with subsequent thrombosis -
embolization - pyemia - hematogenous abscesses
(infected infarctions)
 lymphangiitis, lymphadenitis
 2d. pseudomembranous - fibrinous
pseudomembrane (diphtheria - Corynebacterium,
dysentery - Shigella) - fibrin, necrotic mucosa,
etiologic agens, leucocytes
 2e. necrotizing - inflammatory necrosis of the
surface - ulcer (skin, gastric)
– gangrenous - secondary modification by bacteria - wet
gangrene - apendicitis, cholecystitis - risk of
perforation - peritonitis
Granulomatous inflammationGranulomatous inflammation
distinctive chronic inflammation type
cell mediated immune reaction (delayed)
aggregates of activated macrophages →
epithelioid cell → multinucleated giant cells
(of Langhans type x of foreign body type)
NO agent elimination but walling off
intracellulary agents (TBC)
Granulomatous inflammationGranulomatous inflammation
 1. Bacteria
– TBC
– leprosy
– syphilis (3rd stage)
 2. Parasites + Fungi
 3. Inorganic metals or dust
– silicosis
– berylliosis
 4. Foreign body
– suture (Schloffer „tumor“), breast prosthesis
 5. Unknown - sarcoidosis
Tuberculosis – generalTuberculosis – general
pathologypathology
 1. TBC nodule – proliferative
 Gross: grayish, firm, 1-2 mm (milium) → central
soft yellow necrosis (cheese-like – caseous) →
calcification
 Mi: central caseous necrosis (amorphous
homogenous + karyorrhectic powder) +
macrophages → epithelioid cells →
multinucleated giant cells of Langhans type +
lymphocytic rim
 2. TBC exsudate – sero-fibrinous exsudate
(macrophages)
LeprosyLeprosy
 M. leprae, Asia, Africa
 in dermal macrophages and Schwann cells
 air droplets + long contact
 rhinitis, eyelid destruction, facies leontina
 1. lepromatous – infectious
– skin lesion – foamy macrophages (Virchow cells) +
viscera
 2. tuberculoid – steril
– in peripheral nerves – tuberculoid granulomas -
anesthesia
 death – secondary infections + amyloidosis
SyphilisSyphilis
 Treponema pallidum (spichochete)
 STD + transplacental fetus infection
 acquired (3 stages) x congenital
 basic microspical appearance:
– 1. proliferative endarteritis (endothelial hypertrophy →
intimal fibrosis → local ischemia) + inflammation
(plasma cells)
– 2. gumma – central coagulative necrosis + specific
granulation tissue + fibrous tissue
SyphilisSyphilis
1. primary syphilis - contagious
chancre (ulcus durum, hard chancre)
M: penis x F: vagina, cervix
painless, firm ulceration + regional painless
lymphadenopathy
spontaneous resolve (weeks) → scar
SyphilisSyphilis
2. secondary syphilis - contagious
after 2 months
generalized lymphadenopathy + various
mucocutaneous lesions
condylomata lata - anogenital region, inner
thighs, oral cavity
SyphilisSyphilis
 3. tertiary syphilis
 after long time (5 years)
 1) cardiovascular - syphilitic aortitis (proximal a.)
– endarteritis of vasa vasorum → scaring of media →
dilation → aneurysm
 2) neurosyphilis – tabes dorsalis + general paresis
– degeneration of posterior columns of spinal cord →
sensory + gait abnormality
– cortical atrophy → psychic deterioration
 3) gumma – ulcerative lesions of bone, skin,
mucosa – oral cavity
Congenital syphilisCongenital syphilis
 1) abortus
– hepatomegaly + pancreatitis + pneumonia alba
 2) infantile syphilis
– chronic rhinitis (snuffles) + mucocutaneous lesions
 3) late (tardive, congenital) syphilis
– > 2 years duration
– Hutchinson triad – notched central incisors + keratitis
(blindness) + deafness (injury of n. VIII)
– mulberry molars + saddle nose

Contenu connexe

Tendances

Inflammation
InflammationInflammation
InflammationMUBOSScz
 
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzahkciapm
 
Inflammation ospe rapid review
Inflammation ospe rapid reviewInflammation ospe rapid review
Inflammation ospe rapid reviewdrabbasnaseem
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammationdrshameera
 
Granulomas Dr Manasa Shettisara Janney
Granulomas Dr Manasa Shettisara JanneyGranulomas Dr Manasa Shettisara Janney
Granulomas Dr Manasa Shettisara JanneyManasa Janney
 
Productive inflammation
Productive inflammationProductive inflammation
Productive inflammationnizhgma.ru
 
Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016pathologydept
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammationAj Cocjin
 
Lecture 5 inflammation
Lecture 5 inflammationLecture 5 inflammation
Lecture 5 inflammationGreen-book
 
Covid-19 and IBD - Prof Reidwaan Ally
Covid-19 and IBD - Prof Reidwaan AllyCovid-19 and IBD - Prof Reidwaan Ally
Covid-19 and IBD - Prof Reidwaan AllyConrad Strydom
 

Tendances (20)

Inflammation
InflammationInflammation
Inflammation
 
Leishmaniasis
LeishmaniasisLeishmaniasis
Leishmaniasis
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah4. chronic inflammation  granulomatous inflammation -dr. sinhasan- mdzah
4. chronic inflammation granulomatous inflammation -dr. sinhasan- mdzah
 
Inflammation ospe rapid review
Inflammation ospe rapid reviewInflammation ospe rapid review
Inflammation ospe rapid review
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
Chronic inflammation
Chronic inflammationChronic inflammation
Chronic inflammation
 
chronic inflammation
chronic inflammationchronic inflammation
chronic inflammation
 
Granulomatous lesions of liver
Granulomatous lesions of liver  Granulomatous lesions of liver
Granulomatous lesions of liver
 
Granulomas Dr Manasa Shettisara Janney
Granulomas Dr Manasa Shettisara JanneyGranulomas Dr Manasa Shettisara Janney
Granulomas Dr Manasa Shettisara Janney
 
Productive inflammation
Productive inflammationProductive inflammation
Productive inflammation
 
Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016Chronic inflammation 5 10-2016
Chronic inflammation 5 10-2016
 
Recovery from bacterial infections
Recovery from bacterial infections Recovery from bacterial infections
Recovery from bacterial infections
 
Staphylococcus
StaphylococcusStaphylococcus
Staphylococcus
 
Acute and chronic inflammation
Acute and chronic inflammationAcute and chronic inflammation
Acute and chronic inflammation
 
Lecture 5 inflammation
Lecture 5 inflammationLecture 5 inflammation
Lecture 5 inflammation
 
Covid-19 and IBD - Prof Reidwaan Ally
Covid-19 and IBD - Prof Reidwaan AllyCovid-19 and IBD - Prof Reidwaan Ally
Covid-19 and IBD - Prof Reidwaan Ally
 
Hypersensitivity Reactions
Hypersensitivity ReactionsHypersensitivity Reactions
Hypersensitivity Reactions
 

Similaire à 1inflammation (2)

Inflammation lecture ashish
Inflammation lecture  ashishInflammation lecture  ashish
Inflammation lecture ashishRohit Vermaa
 
Inflammation lecture
Inflammation lecture  Inflammation lecture
Inflammation lecture Ashish Patil
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2hussamdr
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)hussamdr
 
Inflamggvggffgggggggggggmation lecture.ppt
Inflamggvggffgggggggggggmation lecture.pptInflamggvggffgggggggggggmation lecture.ppt
Inflamggvggffgggggggggggmation lecture.pptNaveen764625
 
Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2Rashad Idrees
 
Inflammation acute + chronic
Inflammation  acute + chronic Inflammation  acute + chronic
Inflammation acute + chronic Dr Yaseen Khan
 
Chronic inflammation 2-1-2
Chronic inflammation 2-1-2Chronic inflammation 2-1-2
Chronic inflammation 2-1-2Nimra Iqbal
 
pathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptxpathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptxDishaThakur53
 
Inflammation Lect
Inflammation LectInflammation Lect
Inflammation Lectbilalrana
 
Acute inflammation optimetery lect 2
Acute inflammation optimetery lect 2Acute inflammation optimetery lect 2
Acute inflammation optimetery lect 2Nimra Iqbal
 
Exudative inflammation
Exudative inflammationExudative inflammation
Exudative inflammationnizhgma.ru
 
4. chronic inflammation.pptx
4. chronic inflammation.pptx4. chronic inflammation.pptx
4. chronic inflammation.pptxAndulRehman
 
inflammationfor firsthealthstudents.pptx
inflammationfor firsthealthstudents.pptxinflammationfor firsthealthstudents.pptx
inflammationfor firsthealthstudents.pptxgebrewahidbiniam75
 

Similaire à 1inflammation (2) (20)

1 inflammation
1 inflammation1 inflammation
1 inflammation
 
Inflammation.pptx
Inflammation.pptxInflammation.pptx
Inflammation.pptx
 
Inflammation
InflammationInflammation
Inflammation
 
Inflammation lecture ashish
Inflammation lecture  ashishInflammation lecture  ashish
Inflammation lecture ashish
 
Inflammation lecture
Inflammation lecture  Inflammation lecture
Inflammation lecture
 
Inflammation Part 2
Inflammation Part 2Inflammation Part 2
Inflammation Part 2
 
Inflammation Part (2)
Inflammation Part  (2)Inflammation Part  (2)
Inflammation Part (2)
 
Inflamggvggffgggggggggggmation lecture.ppt
Inflamggvggffgggggggggggmation lecture.pptInflamggvggffgggggggggggmation lecture.ppt
Inflamggvggffgggggggggggmation lecture.ppt
 
Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2Surgery(surgical infections) 1-2
Surgery(surgical infections) 1-2
 
Inflammation acute + chronic
Inflammation  acute + chronic Inflammation  acute + chronic
Inflammation acute + chronic
 
MID2163 TOPIC 3
MID2163 TOPIC 3MID2163 TOPIC 3
MID2163 TOPIC 3
 
Chronic inflammation 2-1-2
Chronic inflammation 2-1-2Chronic inflammation 2-1-2
Chronic inflammation 2-1-2
 
Acute inflammation
Acute inflammationAcute inflammation
Acute inflammation
 
pathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptxpathoinflammation-190307150750.pptx
pathoinflammation-190307150750.pptx
 
Inflammation Lect
Inflammation LectInflammation Lect
Inflammation Lect
 
Acute inflammation optimetery lect 2
Acute inflammation optimetery lect 2Acute inflammation optimetery lect 2
Acute inflammation optimetery lect 2
 
Inflammation
InflammationInflammation
Inflammation
 
Exudative inflammation
Exudative inflammationExudative inflammation
Exudative inflammation
 
4. chronic inflammation.pptx
4. chronic inflammation.pptx4. chronic inflammation.pptx
4. chronic inflammation.pptx
 
inflammationfor firsthealthstudents.pptx
inflammationfor firsthealthstudents.pptxinflammationfor firsthealthstudents.pptx
inflammationfor firsthealthstudents.pptx
 

Dernier

Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...DianaGray10
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024The Digital Insurer
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businesspanagenda
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?Igalia
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024The Digital Insurer
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdflior mazor
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...apidays
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024The Digital Insurer
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDropbox
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processorsdebabhi2
 
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu SubbuApidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbuapidays
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Miguel Araújo
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyKhushali Kathiriya
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Jeffrey Haguewood
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonAnna Loughnan Colquhoun
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...apidays
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native ApplicationsWSO2
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelDeepika Singh
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)wesley chun
 

Dernier (20)

Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
Connector Corner: Accelerate revenue generation using UiPath API-centric busi...
 
AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024AXA XL - Insurer Innovation Award Americas 2024
AXA XL - Insurer Innovation Award Americas 2024
 
Why Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire businessWhy Teams call analytics are critical to your entire business
Why Teams call analytics are critical to your entire business
 
A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?A Year of the Servo Reboot: Where Are We Now?
A Year of the Servo Reboot: Where Are We Now?
 
Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024Axa Assurance Maroc - Insurer Innovation Award 2024
Axa Assurance Maroc - Insurer Innovation Award 2024
 
GenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdfGenAI Risks & Security Meetup 01052024.pdf
GenAI Risks & Security Meetup 01052024.pdf
 
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
Apidays New York 2024 - Accelerating FinTech Innovation by Vasa Krishnan, Fin...
 
FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024FWD Group - Insurer Innovation Award 2024
FWD Group - Insurer Innovation Award 2024
 
DBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor PresentationDBX First Quarter 2024 Investor Presentation
DBX First Quarter 2024 Investor Presentation
 
Exploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone ProcessorsExploring the Future Potential of AI-Enabled Smartphone Processors
Exploring the Future Potential of AI-Enabled Smartphone Processors
 
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu SubbuApidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
Apidays Singapore 2024 - Modernizing Securities Finance by Madhu Subbu
 
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
Mastering MySQL Database Architecture: Deep Dive into MySQL Shell and MySQL R...
 
Artificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : UncertaintyArtificial Intelligence Chap.5 : Uncertainty
Artificial Intelligence Chap.5 : Uncertainty
 
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
Web Form Automation for Bonterra Impact Management (fka Social Solutions Apri...
 
Data Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt RobisonData Cloud, More than a CDP by Matt Robison
Data Cloud, More than a CDP by Matt Robison
 
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data DiscoveryTrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
TrustArc Webinar - Unlock the Power of AI-Driven Data Discovery
 
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
Apidays Singapore 2024 - Building Digital Trust in a Digital Economy by Veron...
 
Architecting Cloud Native Applications
Architecting Cloud Native ApplicationsArchitecting Cloud Native Applications
Architecting Cloud Native Applications
 
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot ModelNavi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
Navi Mumbai Call Girls 🥰 8617370543 Service Offer VIP Hot Model
 
Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)Powerful Google developer tools for immediate impact! (2023-24 C)
Powerful Google developer tools for immediate impact! (2023-24 C)
 

1inflammation (2)

  • 2. InflammationInflammation complex protective reaction caused by various endo- and exogenous stimuli injurious agents are destroyed, diluted or walled-off without inflammation and mechanism of healing could organism not survive can be potentially harmfull
  • 3. TerminologyTerminology Greek root + -itis metritis, not uteritis kolpitis, not vaginitis nephritis, not renitis
  • 4. MechanismsMechanisms  local - in cases of mild injury  systemic  3 major:  1. alteration  2. exsudation - inflammatory exsudate – liquid (exsudate) – cellular (infiltrate)  3. proliferation (formation of granulation and fibrous tissue)  usualy - all 3 components - not the same intensity
  • 5. ClassificationClassification  several points of view  length: – acute × chronic (+ subacute, hyperacute)  according to predominant component – 1. alterative (predominance of necrosis - diphtheria) – 2. exsudative (pleuritis) – 3. proliferative (cholecystitis - thickening of the wall by fibrous tissue)
  • 6. ClassificationClassification  according to histological features – nonspecific (not possible to trace the etiology) - vast majority – specific (e.g. TB)  according to causative agent – aseptic (sterile) - chemical substances, congelation, radiation - inflammation has a reparative character – septic (caused by living organisms) - inflammation has a protective character
  • 7. Acute inflammationAcute inflammation important role in inflammation has microcirculation! supply of white blood cells, interleukins, fibrin, etc.
  • 8. Local symptomatologyLocal symptomatology classical 5 symptoms (Celsus 1st c. B.C., Virchow 19th c. A.D.) 1. calor - heat 2. rubor - redness 3. tumor - swelling 4. dolor - pain 5. functio laesa - loss (or impairment) of function
  • 9. Systemic symptomatologySystemic symptomatology  fever (irritation of centre of thermoregulation) – TNF, IL-1 – IL-6 – high erythrocyte sedimentation rate  leucocytosis - increased number of WBC – bacteria – neutrophils – parasites – eosinophils – viruses - lymphocytosis  leucopenia - decreased " " – viral infections, salmonella infections, rickettsiosis  immunologic reactions - increased level of some substances (C-reactive protein)
  • 10. Vascular changesVascular changes  vasodilation – increased permeability of vessels due to widened intercell. junctions and contraction of endothelial cells (histamin, VEGF, bradykinin)  protein poor transudate (edema)  protein rich exsudate  leukocyte-dependent endothelial injury – proteolysis – protein leakage  → platelet adhesion → thrombosis
  • 11. Cellular eventsCellular events  leukocytes margination → rolling → adhesion → transmigration  emigration of: – neutrophils (1-2 days) – monocytes (2-3 days)  chemotaxis – endogenous signaling molecules - lymphokines – exogenous - toxins  phagocytosis - lysosomal enzymes, free radicals, oxidative burst  passive emigration of RBC - no active role in inflamm. - hemorrhagic inflammation
  • 12. PhagocytosisPhagocytosis adhesion and invagination into cytoplasm engulfment lysosomes - destruction in highly virulent microorganisms can die leucocyte and not the microbe in highly resistant microorganisms - persistence within macrophage - activation after many years
  • 13. Outcomes of acute inflammationOutcomes of acute inflammation  1. resolution - restoration to normal, limited injury – chemical substances neutralization – normalization of vasc. permeability – apoptosis of inflammatory cells – lymphatic drainage  2. healing by scar – tissue destruction – fibrinous inflammtion – purulent infl. → abscess formation (pus, pyogenic membrane, resorption - pseudoxanthoma cells - weeks to months)  3. progression into chronic inflammation
  • 14. Chronic inflammationChronic inflammation reasons: – persisting infection or prolonged exposure to irritants (intracell. surviving of agents - TBC) – repeated acute inflamations (otitis, rhinitis) – primary chronic inflammation - low virulence, sterile inflammations (silicosis) – autoimmune reactions (rheumatoid arthritis, glomerulonephritis, multiple sclerosis)
  • 15. Chronic inflammationChronic inflammation  chronic inflammatory cells ("round cell" infiltrate) – lymphocytes – plasma cells – monocytes/macrophages activation of macrophages by various mediators - fight against invaders  lymphocytes → plasma cells, cytotoxic (NK) cells, coordination with other parts of immune system  plasma cells - production of Ig  monocytes-macrophages-specialized cells (siderophages, gitter cells, mucophages)
  • 16. Morphologic patterns ofMorphologic patterns of inflammationinflammation  1. alterative  2. exsudative – 2a. serous – 2b. fibrinous – 2c. suppurative – 2d. pseudomembranous – 2e. necrotizing, gangrenous  3. proliferative – primary (rare) x secondary (cholecystitis)
  • 17. Morphologic patterns ofMorphologic patterns of inflammationinflammation  2a. serous - excessive accumulation of fluid, few proteins - skin blister, serous membranes - initial phases of inflamm.  modification - catarrhal - accumulation of mucus  2b. fibrinous - higher vascular permeability - exsudation of fibrinogen -> fibrin - e.g. pericarditis (cor villosum, cor hirsutum - "hairy" heart  fibrinolysis → resolution; organization → fibrosis → scar
  • 18.  2c. suppurative (purulent) - accumulation of neutrophillic leucocytes - formation of pus (pyogenic bacteria)  interstitial – phlegmone – diffuse soft tissue – abscess - localized collection  acute – border – surrounding tissue  chronic – border - pyogenic membrane  Pseudoabscess – pus in lumen of hollow organ  formation of suppurative fistule  accumulation of pus in preformed cavities - empyema (gallbladder, thoracic)
  • 19.  complications of suppurative inflamm.:  bacteremia (no clinical symptoms!; danger of formation of secondary foci of inflamm. (endocarditis, meningitis)  sepsis (= massive bacteremia) - septic fever, activation of spleen, septic shock  thrombophlebitis - secondary inflammation of wall of the vein with subsequent thrombosis - embolization - pyemia - hematogenous abscesses (infected infarctions)  lymphangiitis, lymphadenitis
  • 20.  2d. pseudomembranous - fibrinous pseudomembrane (diphtheria - Corynebacterium, dysentery - Shigella) - fibrin, necrotic mucosa, etiologic agens, leucocytes  2e. necrotizing - inflammatory necrosis of the surface - ulcer (skin, gastric) – gangrenous - secondary modification by bacteria - wet gangrene - apendicitis, cholecystitis - risk of perforation - peritonitis
  • 21. Granulomatous inflammationGranulomatous inflammation distinctive chronic inflammation type cell mediated immune reaction (delayed) aggregates of activated macrophages → epithelioid cell → multinucleated giant cells (of Langhans type x of foreign body type) NO agent elimination but walling off intracellulary agents (TBC)
  • 22. Granulomatous inflammationGranulomatous inflammation  1. Bacteria – TBC – leprosy – syphilis (3rd stage)  2. Parasites + Fungi  3. Inorganic metals or dust – silicosis – berylliosis  4. Foreign body – suture (Schloffer „tumor“), breast prosthesis  5. Unknown - sarcoidosis
  • 23. Tuberculosis – generalTuberculosis – general pathologypathology  1. TBC nodule – proliferative  Gross: grayish, firm, 1-2 mm (milium) → central soft yellow necrosis (cheese-like – caseous) → calcification  Mi: central caseous necrosis (amorphous homogenous + karyorrhectic powder) + macrophages → epithelioid cells → multinucleated giant cells of Langhans type + lymphocytic rim  2. TBC exsudate – sero-fibrinous exsudate (macrophages)
  • 24. LeprosyLeprosy  M. leprae, Asia, Africa  in dermal macrophages and Schwann cells  air droplets + long contact  rhinitis, eyelid destruction, facies leontina  1. lepromatous – infectious – skin lesion – foamy macrophages (Virchow cells) + viscera  2. tuberculoid – steril – in peripheral nerves – tuberculoid granulomas - anesthesia  death – secondary infections + amyloidosis
  • 25. SyphilisSyphilis  Treponema pallidum (spichochete)  STD + transplacental fetus infection  acquired (3 stages) x congenital  basic microspical appearance: – 1. proliferative endarteritis (endothelial hypertrophy → intimal fibrosis → local ischemia) + inflammation (plasma cells) – 2. gumma – central coagulative necrosis + specific granulation tissue + fibrous tissue
  • 26. SyphilisSyphilis 1. primary syphilis - contagious chancre (ulcus durum, hard chancre) M: penis x F: vagina, cervix painless, firm ulceration + regional painless lymphadenopathy spontaneous resolve (weeks) → scar
  • 27. SyphilisSyphilis 2. secondary syphilis - contagious after 2 months generalized lymphadenopathy + various mucocutaneous lesions condylomata lata - anogenital region, inner thighs, oral cavity
  • 28. SyphilisSyphilis  3. tertiary syphilis  after long time (5 years)  1) cardiovascular - syphilitic aortitis (proximal a.) – endarteritis of vasa vasorum → scaring of media → dilation → aneurysm  2) neurosyphilis – tabes dorsalis + general paresis – degeneration of posterior columns of spinal cord → sensory + gait abnormality – cortical atrophy → psychic deterioration  3) gumma – ulcerative lesions of bone, skin, mucosa – oral cavity
  • 29. Congenital syphilisCongenital syphilis  1) abortus – hepatomegaly + pancreatitis + pneumonia alba  2) infantile syphilis – chronic rhinitis (snuffles) + mucocutaneous lesions  3) late (tardive, congenital) syphilis – > 2 years duration – Hutchinson triad – notched central incisors + keratitis (blindness) + deafness (injury of n. VIII) – mulberry molars + saddle nose